Roche
Search results
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. [4] [5]
Novartis Singapore. Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
Mar 15, 2024 · SINGAPORE - Swiss pharmaceutical giant Novartis is spending US$256 million (S$342.3 million) to expand its biopharmaceutical manufacturing plant here. The enlarged facility is expected to be ...
May 23, 2024 · Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative ...
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Sep 28, 2021 · Novartis receives approval in Singapore for LEQVIO® (inclisiran), an innovative medication that changes the treatment paradigm for patients with high cholesterol. Sep 28, 2021. Leqvio® (inclisiran) is an innovative medicine that can change how low-density lipoprotein cholesterol (LDL-C) or commonly known as bad cholesterol is ...
Search for careers at Novartis and discover our diverse and inclusive teams where we collaborate to bring innovative products to life.
SWISS biopharma giant Novartis has invested US$256 million to expand its biopharmaceutical manufacturing plant in Singapore. The expanded site will focus on manufacturing therapeutic antibody drugs.
Mar 15, 2024 · Novartis breaks ground on $256 million expansion of biopharmaceutical manufacturing plant in Singapore. Investment focuses on deploying digital and automation solutions to boost productivity, efficiency, and workforce skills.
